SMSbiotech, Inc

Welcome to the Future of Medicine and Research

 

Cutting Edge

Stem Cell Technology

 

Groundbreaking Products

ANGIOstream

A Stem Cell Based, Enabling Technology Company

SMSbiotech, Inc. is a California-based biotech company. Our goal is to revolutionize how the life sciences industry explores, examines, assesses and manipulates cells, drugs and toxins. SMSbiotech stem cell technology will lead to the development of more efficient and relevant medicines that will serve a broad spectrum of patients and reduce the overall costs of health care.

SMSbiotech:

  • Provides a novel, patented approach that can produce unique human autologous and allogeneic adult stem cells at an industrial scale.
  • Manufactures complex human extracellular matrices (ECMs).
  • Manufactures ECMs for therapeutic purposes.
  • Produces human ECMs with unique angiogenic capabilities for use in research and development.

The Science

Human extracellular matrices (ECM) derived from Small Mobile Stem (SMS) cells.

learn more

The Challenges

The chronic wound “epidemic” was estimated to affect 6.7 million patients in 2016.

learn more

The Solutions

The extracellular matrix, a complex composite substance, is a major component of our body.

learn more

Our Mission

Democratizing the application of adult stem cell technologies for human health.

learn more

Who We Are

SMSbiotech was founded based on its revolutionary adult stem cell research. Through a combination of hard work and over three decades of experience in research and applications, we have been able to patent a new platform technology. Our technology will change the way that life science industries approach the research of cells, drugs and toxins by providing a wide spectrum of medical applications.

learn more